Glucopyranosyl lipid adjuvant enhances immune response to Ebola virus-like particle vaccine in mice
Melek M. E. Sunay(United States Army Medical Research Institute of Infectious Diseases), Sina Bavari(Epix Pharmaceuticals (United States)), Neal Van Hoeven(Sana Biotechnology (United States)), Preston G. Garnes(Infectious Disease Research Institute), Jesse Steffens(United States Army Medical Research Institute of Infectious Diseases), Sean Vantongeren(United States Army Medical Research Institute of Infectious Diseases), Karen Martins(Biomedical Advanced Research and Development Authority), Melissa K. Gregory(United States Army Medical Research Institute of Infectious Diseases)
Cited by 20
Related Papers
Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial
|Science|2022|1.2k
A Two-Amino Acid Change in the Hemagglutinin of the 1918 Influenza Virus Abolishes Transmission
|Science|2007|582
Taxonomy of the order Mononegavirales: update 2016
|Archives of Virology|2016|506
Lactobacilli activate human dendritic cells that skew T cells toward T helper 1 polarization
|Proceedings of the National Academy of Sciences|2005|470
Dendrimer-RNA nanoparticles generate protective immunity against lethal Ebola, H1N1 influenza, and <i>Toxoplasma gondii</i> challenges with a single dose
|Proceedings of the National Academy of Sciences|2016|405